Navigation Links
Synthetic Biologics Reports First Quarter 2013 Financial Results
Date:5/15/2013

ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, today reported financial results for the three months ended March 31, 2013 and summarized operational highlights.

Operational HighlightsEmphasis on C. difficile (C. diff) Infection Prevention (SYN-004)

  • In the U.S. each year, 24 million patients are administered IV antibiotics[1] which may be excreted into the gastrointestinal (GI) tract where they can upset the natural balance of the microbiome allowing for the overgrowth of C. difficile which causes diarrhea, colitis and may result in death.
  • SYN-004 is being developed as an oral enzyme product to be co-administered with IV beta-lactam antibiotics. SYN-004 is expected to:
  • Remain in the GI tract to degrade certain beta-lactam antibiotics
  • Protect the healthy microflora from the overgrowth of C. diff
  • In 2012, over 13 million patients were treated with IV beta-lactam antibiotics that may be covered by SYN-004.[1]
  • Phase I and II studies of over 200 subjects treated with 1st generation candidate demonstrated safety, tolerability, and preservation of the normal GI microflora when co-administered with certain penicillins.
  • Infectious Disease Specialist Joins Scientific Advisory Board

  • Brad Spellberg , M.D., is an Associate Professor of Medicine, David Geffen School of Medicine in the Division of General Internal Medicine at Harbor-UCLA Medical Center, and Associate Program Director for Internal Medicine Residency Training Program, Harbor-UCLA Medical Center and LA BioMed.
  • Dr. Spellberg has worked closely with the Infectious Diseases Society of America (IDSA) to focus attention on the rising public health
    '/>"/>

  • SOURCE Synthetic Biologics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
    2. Details of New Synthetic Vaccine for Emerging H7N9 Threat Revealed at BIO International Convention in Chicago, April 22-25
    3. Synthetic Biologics Reports Year End 2012 Financial Results
    4. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
    5. Synthetic Biologics to Present at the 25th Annual ROTH Conference
    6. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
    7. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
    8. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
    9. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
    10. The Use of New Replikins Synthetic Vaccines to Prevent Pandemics to be Presented at Influenza Congress Nov. 12 in Washington DC
    11. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... , July 30, 2015   Gaumard® Scientific ... to UNI®, the world,s first operating system to ... now available exclusively to Gaumard users. UNI® version ... launched Newborn Tory™ S2200, as well as improvements ... of clinical measures such as EtCO 2 .  ...
    (Date:7/30/2015)... What can be expected from ... going to grow at the fastest rates? Visiongain ... 2025, assessing data, trends, opportunities and prospects there. ... charts, and graphs. Discover the most lucrative areas in ... study lets you assess forecasted sales at overall world ...
    (Date:7/30/2015)... DIEGO , July 30, 2015  Arena Pharmaceuticals, ... host a conference call and webcast at 5:00 p.m. ... 5, 2015, to discuss second quarter 2015 financial results ... financial results after the NASDAQ Global Select Market closes ... accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 ...
    Breaking Medicine Technology:Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4
    ... Jan. 27 Notal Vision,s ForeseeHome™ ... U.S. Food and Drug Administration (FDA). , The ForeseeHome AMD ... between eye exams for ongoing monitoring of age-related macular degeneration ... ForeseeHome AMD Monitor, in the comfort of their own home, ...
    ... , RICHMOND, Calif. , Jan. 27 Sangamo ... release its fourth quarter and full year 2009 financial results on ... will be followed by a conference call at 5:00 p.m. ET ... During the conference call, the company will review the financial results and ...
    Cached Medicine Technology:Notal Vision's ForeseeHome(TM) AMD Monitor Receives FDA Clearance 2Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast 2
    (Date:7/30/2015)... ... July 31, 2015 , ... ... 50% or More, **Presented by FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, ... year veteran of helping drug, biologic and device firms reduce manufacturing errors by ...
    (Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace Bay in the ... Guests who stay at the Venetian will save 40% on their stay while enjoying some ... always quiet in the Turks & Caicos, providing a chance to reconnect with loved ones ...
    (Date:7/30/2015)... , ... July 31, 2015 , ... On July 22nd ... in Manatee county to discuss plausible solutions for controlling the heroin outbreak. Ultimately the ... of an overdose is largely perpetuating the heroin crisis in North Florida. The task ...
    (Date:7/30/2015)... ... , ... Committed to helping the next generation succeed - Mercy College is ... the College’s “My Brother’s Keeper Scholarship.” The President’s signature initiative issues a call to ... support they need to think more broadly about their future. Building on what works ...
    (Date:7/30/2015)... ... 30, 2015 , ... World Patent Marketing, a vertically integrated ... that can help people during emergencies. , "The worldwide mobile health market revenue ... of World Patent Marketing. "Currently, there are about 97,000 mobile health apps available ...
    Breaking Medicine News(10 mins):Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5
    ... and pressure ulcers, are associated with an increased ... have suffered a hip fracture, according to a ... for Aging Research at Hebrew SeniorLife. , "Prevention ... help reduce mortality in this frail population," says ...
    ... Visionworks, a leading national provider of eye care services, ... bringing their total number of stores in the area to ... Orlando and Osceola Village in Kissimmee on May 1. ... over 15 years. Visionworks is a full-service optical ...
    ... are tough, adults 60 and over may qualify for a ... Economic Recovery Act, benefits have risen for the first time ... the cost of groceries and Medicare premiums, if people invest ... MiCAFE stands for Michigan,s Coordinated Access to Food for the ...
    ... Million by 2014PRINCETON, N.J., May 22 New Jersey ... next year and more than $500 million over the ... to take effect in October, according to an analysis ... examined the impact of three provisions under the Centers ...
    ... anti-tumor drugs is a hot research area. Chrysin ... reported to have many different biological activities such ... effect. However, Chrysin is limited in its clinical ... intestine and rapid in vivo glycosylation. To improve ...
    ... Non-steroidal anti-inflammatory drugs (NSAIDs), which are known to reduce ... (COX2) and reduce its activity. Population studies have found ... with colon cancer risk, but others were unable to ... glucuronosyltransferase 1A6 (UGT1A6) gene, which is also known to ...
    Cached Medicine News:Health News:Institute for Aging Research finds modifiable hip fracture complications contribute to mortality 2Health News:National Eyewear Chain Visionworks Opens Two New Stores in Orlando Market 2Health News:A Bright Spot - Financial Help for Seniors 2Health News:N.J. Hospitals Face $97 Million in Medicare Cuts 2Health News:N.J. Hospitals Face $97 Million in Medicare Cuts 3Health News:A potential drug for liver carcinoma 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: